Showing results (181-190 of 332) with videos related to
Sort By:
Pageof 34
Neurology and Therapy|March 24, 2019
Efficacy and Safety of Octagam® in Patients With Chronic Inflammatory Demyelinating PolyneuropathyChafké Belmokhtar, Pierre Lozeron, David Adams, et al.Molecular Genetics and Metabolism|April 29, 2009
Hermansky-Pudlak syndrome type 1 in patients of Indian descentLisa M Vincent, David Adams, Richard A Hess, et al.Archives of Cardiovascular Diseases|June 20, 2012
Circadian rhythm of blood pressure reflects the severity of cardiac impairment in familial amyloid polyneuropathyVincent Algalarrondo, Ludivine Eliahou, Isabelle Thierry, et al.Orphanet Journal of Rare Diseases|March 2, 2025
Diagnosis of hereditary transthyretin amyloidosis in patients with suspected chronic inflammatory demyelinating polyneuropathy unresponsive to intravenous immunoglobulins: results of a retrospective studyYann Péréon, David Adams, Jean-Philippe Camdessanché, et al.Medicine|July 25, 2006
Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathyNicolas Delahaye, François Rouzet, Laure Sarda, et al.Heart Rhythm|September 25, 2021
Successful continuous positive airway pressure treatment reduces skin sympathetic nerve activity in patients with obstructive sleep apneaGuannan Meng, Wenbo He, Johnson Wong, et al.The British Journal of Ophthalmology|January 18, 2020
Conjunctival lymphangiectasia as a biomarker of severe systemic disease in Ser77Tyr hereditary transthyretin amyloidosisRoxane Bunod, David Adams, Cécile Cauquil, et al.Neurology|July 26, 2015
Rapid progression of familial amyloidotic polyneuropathy: a multinational natural history studyDavid Adams, Teresa Coelho, Laura Obici, et al.American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|September 1, 2020
The peroxisomal disorder spectrum and Heimler syndrome: Deep phenotyping and review of the literatureMalena Daich Varela, Priyam Jani, Wadih M Zein, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2022
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantationHartmut H Schmidt, Jonas Wixner, Violaine Planté-Bordeneuve, et al.Pageof 34